Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

19831 - 19840 of 44979 results found

Therapy challenges for NMOSD in a patient with HIV

Date
Friday, September 15, 2023 - 4:00 AM
Description
Neuromyelitis optica spectrum disorder (NMOSD) in people living with HIV (PLWH) is rare and its management can be difficult. Here we report a case of an HIV patient with bilateral vision loss, who was diagnosed with AQP4-IgG-positive NMOSD in 2020

Association between Racial Residential Segregation and COVID-19 Mortality

Date
Friday, September 15, 2023 - 4:00 AM
Description
This study investigates the impact of racial residential segregation on COVID-19 mortality during the first year of the US epidemic. Data comes from the Center for Disease Control and Prevention (CDC), and the Robert Wood Johnson Foundation's and the

Acute invasive fungal rhinosinusitis in post-COVID-19 patients in Vietnam

Date
Friday, September 15, 2023 - 4:00 AM
Description
CONCLUSION: The presence of meningitis upon initial diagnosis is related to a significantly higher chance of developing a fatal outcome and should be considered, especially in AIFR patients previously treated for COVID-19 infections. Early diagnosis

New-onset minimal change disease following the Moderna COVID-19 vaccine

Date
Friday, September 15, 2023 - 4:00 AM
Description
We report the case of nephrotic syndrome after COVID-19 vaccination. The patient was a man in his 30s with no comorbidities other than atopic dermatitis. Over the course of 2 weeks after the first COVID-19 vaccination, systemic oedema gradually

RNA nanotechnology: A new chapter in targeted therapy

Date
Friday, September 15, 2023 - 4:00 AM
Description
Nanoparticles have been widely studied in the fields of biotechnology, pharmacy, optics and medicine and have broad application prospects. Numerous studies have shown significant interest in utilizing nanoparticles for chemically coating or coupling

A synthetic delivery vector for mucosal vaccination

Date
Friday, September 15, 2023 - 4:00 AM
Description
The success of mRNA-based vaccines during the Covid-19 pandemic has highlighted the value of this new platform for vaccine development against infectious disease. However, the CD8^(+) T cell response remains modest with mRNA vaccines, and these do